p53-Independent Activation of the gadd45 Promoter by Δ12-Prostaglandin J2
暂无分享,去创建一个
T. Sakai | S. Mimaki | S. Dao | N. Ohtani‐Fujita | S. Minami
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] P. O'Connor,et al. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. , 1996, Oncogene.
[3] R. Umek,et al. C/EBPalpha regulation of the growth-arrest-associated gene gadd45 , 1996, Molecular and cellular biology.
[4] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[5] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[6] J. Chen,et al. Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death. , 1995, The Journal of clinical investigation.
[7] A. Ichikawa,et al. Identification of a cis-Regulatory Element for Δ12-Prostaglandin J2-induced Expression of the Rat Heme Oxygenase Gene (*) , 1995, The Journal of Biological Chemistry.
[8] Jeong-Hwa Lee,et al. Induction of p53 and apoptosis by δ 12‐PGJ2 in human hepatocarcinoma SK‐HEP‐1 cells , 1995 .
[9] L. Cox,et al. Characterisation of the interaction between PCNA and Gadd45. , 1995, Oncogene.
[10] F. Vikhanskaya,et al. Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genes , 1995, International journal of cancer.
[11] P. O'Connor,et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.
[12] A. Fornace,et al. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. , 1994, Cancer research.
[13] N. Park,et al. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. , 1994, Oncogene.
[14] A. Fornace,et al. The p53-dependent γ-Ray Response of GADD45 , 1994 .
[15] A. Fornace,et al. Analysis of the mammalian gadd45 gene and its response to DNA damage. , 1993, The Journal of biological chemistry.
[16] Jeong-Hwa Lee,et al. Prostaglandin A2 and Δ12‐prostaglandin J2 induce apoptosis in L1210 cells , 1993 .
[17] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[18] M. Fukushima. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.
[19] J. Fargnoli,et al. Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd153 mRNA. , 1992, Experimental cell research.
[20] N. Chandar,et al. Inactivation of p53 gene in human and murine osteosarcoma cells. , 1992, British Journal of Cancer.
[21] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[22] B. Vogelstein,et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.
[23] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.
[24] A. Brasier,et al. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. , 1989, BioTechniques.
[25] J. Fargnoli,et al. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents , 1989, Molecular and cellular biology.
[26] W. Smith,et al. The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.
[27] S. Narumiya,et al. Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. , 1988, The Journal of biological chemistry.
[28] S. Narumiya,et al. Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells. , 1988, The Journal of pharmacology and experimental therapeutics.
[29] S. Narumiya,et al. Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei. , 1987, The Journal of pharmacology and experimental therapeutics.
[30] A. Schneider-Gädicke,et al. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. , 1986, The EMBO journal.